Positive Spillovers and Free Riding in Advertising of Prescription Pharmaceuticals: The Case of Antidepressants

Exploiting the discontinuity in advertising along the borders of television markets, I estimate that television advertising of prescription antidepressants exhibits significant positive spillovers on rivals' demand. I apply this identification in a demand model, where estimated parameters indicate significant and persistent spillovers driven by market expansion. Using the demand estimates to calibrate a stylized supply model, I explore the consequences of the positive spillovers on firm advertising choice. Compared with a competitive benchmark in which firms optimally free ride, simulations suggest that a category-wide advertising cooperative would produce a significant increase in total advertising.

[1]  M. S. Goeree,et al.  LIMITED INFORMATION AND ADVERTISING IN THE U.S. PERSONAL COMPUTER INDUSTRY , 2008 .

[2]  Rahman Azari,et al.  Influence of patients' requests for direct-to-consumer advertised antidepressants: a randomized controlled trial. , 2005, JAMA.

[3]  K. Arrow,et al.  OPTIMAL ADVERTISING POLICY UNDER DYNAMIC CONDITIONS , 1962 .

[4]  M. Nerlove,et al.  Biases in dynamic models with fixed effects , 1988 .

[5]  Puneet Manchanda,et al.  An Empirical Model of Advertising Dynamics , 2004 .

[6]  Koichiro Ito,et al.  Do Consumers Respond to Marginal or Average Price? Evidence from Nonlinear Electricity Pricing , 2012 .

[7]  Sandra E. Black.  Do better schools matter? Parental valuation of elementary education , 1999 .

[8]  Michael Sinkinson,et al.  Ask Your Doctor? Direct-to-Consumer Advertising of Pharmaceuticals , 2015 .

[9]  M. Reich,et al.  Minimum Wage Effects Across State Borders: Estimates Using Contiguous Counties , 2007, The Review of Economics and Statistics.

[10]  Qiang Liu,et al.  The Impact of Direct-to-Consumer Advertising of Prescription Drugs on Physician Visits and Drug Requests: Empirical Findings and Public Policy Implications , 2011 .

[11]  D. Rosielle,et al.  Psychiatry , 1905, NeuroImage.

[12]  Ernst R Berndt,et al.  Effects of Pharmaceutical Promotion on Adherence to the Treatment Guidelines for Depression , 2004, Medical care.

[13]  G. Urban,et al.  Information, marketing, and pricing in the U.S. antiulcer drug market. , 1995, The American economic review.

[14]  I. Anderson,et al.  Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability. , 2000, Journal of affective disorders.

[15]  Fiona M. Scott Morton,et al.  The Distortionary Effects of Government Procurement: Evidence from Medicaid Prescription Drug Purchasing , 2004 .

[16]  David Card,et al.  Minimum Wages and Employment: A Case Study of the Fast Food Industry in New Jersey and Pennsylvania , 1993 .

[17]  Peter E. Rossi,et al.  Response Modeling with Non-Random Marketing Mix Variables , 2003 .

[18]  Ernst R. Berndt,et al.  The Practice of Econometrics: Classic and Contemporary. , 1992 .

[19]  Steven T. Berry.  Estimating Discrete-Choice Models of Product Differentiation , 1994 .

[20]  Darren Filson.  The Impacts of Price Controls on the Performance of the Pharmaceutical Industry , 2007 .

[21]  Bradley T. Shapiro,et al.  The Regulation of Prescription Drug Competition and Market Responses: Patterns in Prices and Sales Following Loss of Exclusivity , 2013 .

[22]  G. Jin,et al.  Direct to Consumer Advertising and Prescription Choice , 2007 .

[23]  M. Dickstein.  Efficient Provision of Experience Goods: Evidence from Antidepressant Choice , 2018 .

[24]  G. Jin,et al.  The Effect of Prescription Drug Advertising on Doctor Visits , 2005 .

[25]  Daniel Klapper,et al.  Super Bowl Ads , 2016, Mark. Sci..

[26]  R. Dorfman,et al.  Optimal Advertising and Optimal Quality , 1976 .

[27]  Eric T. Anderson,et al.  Advertising in a Competitive Market: The Role of Product Standards, Customer Learning, and Switching Costs , 2013 .

[28]  Toshiaki Iizuka.  What Explains the Use of Direct-to-Consumer Advertising of Prescription Drugs? , 2004 .

[29]  D. Kessler,et al.  Demand Effects of Recent Changes in Prescription Drug Promotion , 2003 .

[30]  Andrew T. Ching.  A Dynamic Oligopoly Structural Model for the Prescription Drug Market after Patent Expiration , 2009 .

[31]  Catherine Wolfram,et al.  Coordinating on lower prices: pharmaceutical pricing under political pressure. , 2006, The Rand journal of economics.

[32]  Glenn Ellison,et al.  Strategic Entry Deterrence and the Behavior of Pharmaceutical Incumbents Prior to Patent Expiration , 2007 .

[33]  E. Berndt,et al.  Demand Effects of Recent Changes in Prescription Drug Promotion , 2003 .

[34]  E. Berndt,et al.  Effects of Direct-to-Consumer Advertising on Medication Choice: The Case of Antidepressants , 2004 .

[35]  Qiang Liu,et al.  The Cross Attributes Flexible Substitution Logit: Uncovering Category Expansion and Share Impacts of Marketing Instruments , 2015, Mark. Sci..

[36]  Andrew T. Ching,et al.  The Effects of Publicity on Demand: The Case of Anti-Cholesterol Drugs , 2015, Mark. Sci..

[37]  Sriram Venkataraman,et al.  The Relationship between DTCA, Drug Requests and Prescriptions: Uncovering Variation in Specialty and Space , 2012, Mark. Sci..

[38]  Sridhar Narayanan,et al.  Return on Investment Implications for Pharmaceutical Promotional Expenditures: The Role of Marketing-Mix Interactions , 2004 .

[39]  W. Millar,et al.  Going to the doctor. , 2007, Health reports.

[40]  J. Jayawardhana.  Direct-to-consumer advertising and consumer welfare , 2013 .

[41]  Randall Lewis,et al.  Wasn ’ t That Ad for an iPad ? Display Advertising ’ s Impact on Advertiser-and Competitor-Branded Search , 2012 .

[42]  M. Wosinska,et al.  Just What the Patient Ordered? Direct-to-Consumer Advertising and the Demand for Pharmaceutical Products , 2002 .

[43]  Qiang Liu,et al.  An Empirical Model of Drug Detailing: Dynamic Competition and Policy Implications , 2015, Manag. Sci..

[44]  Andrew T. Ching,et al.  Measuring the Informative and Persuasive Roles of Detailing on Prescribing Decisions , 2010, Manag. Sci..

[45]  K. Bagwell.  The Economic Analysis of Advertising , 2005 .

[46]  Tülin Erdem,et al.  The Price Consideration Model of Brand Choice , 2009 .

[47]  C. Lewis,et al.  The impact of direct-to-consumer advertising. , 2003, FDA consumer.

[48]  M. Wosinska.  Direct-to-Consumer Advertising and Drug Therapy Compliance , 2005 .

[49]  Sachin Gupta,et al.  An Empirical Model of Drug Detailing: Dynamic Competition and Policy Implications , 2015 .

[50]  K. Simon,et al.  The impact of direct-to-consumer television and magazine advertising on antidepressant use. , 2012, Journal of health economics.